FDA Approves COLESTIPOL HYDROCHLORIDE — Amneal Pharmaceuticals of New York LLC

# FDA Approves Amneal Pharmaceuticals' Generic Colestipol Hydrochloride Amneal Pharmaceuticals of New York LLC received FDA approval for its generic colestipol hydrochloride oral formulation, expanding the competitive landscape in the bile acid sequestrant market and potentially increasing access to this cholesterol-management therapy at lower costs. The approval of this generic alternative to the branded medication is expected to drive pricing pressure in the segment and capture market share from existing colestipol products.